[{"Assets_0_Q2_USD":211433000.0,"CommonStockSharesOutstanding_0_Q2_shares":79165819.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-31777000.0,"NetIncomeLoss_1_Q2_USD":-27732000.0,"NetIncomeLoss_2_Q2_USD":-55251000.0,"StockholdersEquity_0_Q2_USD":181631000.0,"Ticker":"IBRX","CIK":"1326110","name":"NANTKWEST, INC.","OfficialName":"ImmunityBio Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1985576569.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20180806"}]